+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Coronary Artery Bypass Grafts (CABG): Global Strategic Business Report

  • PDF Icon

    Report

  • 194 Pages
  • October 2022
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5028032

Global Coronary Artery Bypass Grafts (CABG) Market to Reach $178 Million by 2027

In the changed post COVID-19 business landscape, the global market for Coronary Artery Bypass Grafts (CABG) estimated at US$130.9 Million in the year 2020, is projected to reach a revised size of US$178 Million by 2027, growing at a CAGR of 4.5% over the analysis period 2020-2027. Off-Pump, one of the segments analyzed in the report, is projected to record a 4.1% CAGR and reach US$85.5 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the On-Pump segment is readjusted to a revised 3.3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $38.5 Million, While China is Forecast to Grow at 4.2% CAGR

The Coronary Artery Bypass Grafts (CABG) market in the U.S. is estimated at US$38.5 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$31.6 Million by the year 2027 trailing a CAGR of 4.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.3% and 3.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Minimally Invasive Direct Segment to Record 8.3% CAGR

In the global Minimally Invasive Direct segment, USA, Canada, Japan, China and Europe will drive the 8.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$15.6 Million in the year 2020 will reach a projected size of US$27.3 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.

Select Competitors (Total 41 Featured) -

  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Genesee BioMedical, Inc.
  • Hancock Jaffe Laboratories, Inc.
  • HeartWare International, Inc.
  • Karl Storz GmbH & Co. KG
  • Maquet Holding B.V. & Co. KG
  • Medtronic PLC
  • Novadaq Technologies, Inc.
  • TandemLife

What's New for 2022?

  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and a Research Platform
  • Complimentary updates for one year
Frequently Asked Questions about the Global Market for Coronary Artery Bypass Grafts (CABG)

What is the estimated value of the Global Market for Coronary Artery Bypass Grafts (CABG)?

The Global Market for Coronary Artery Bypass Grafts (CABG) was estimated to be valued at $130.9 Million in 2020.

What is the growth rate of the Global Market for Coronary Artery Bypass Grafts (CABG)?

The growth rate of the Global Market for Coronary Artery Bypass Grafts (CABG) is 4.5%, with an estimated value of $178 Million by 2027.

What is the forecasted size of the Global Market for Coronary Artery Bypass Grafts (CABG)?

The Global Market for Coronary Artery Bypass Grafts (CABG) is estimated to be worth $178 Million by 2027.

Who are the key companies in the Global Market for Coronary Artery Bypass Grafts (CABG)?

Key companies in the Global Market for Coronary Artery Bypass Grafts (CABG) include Abbott Laboratories, Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Genesee BioMedical, Inc., Hancock Jaffe Laboratories, Inc., HeartWare International, Inc., Karl Storz GmbH & Co. KG, Maquet Holding B.V. & Co. KG and Novadaq Technologies, Inc..

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • Coronary Artery Bypass Grafts (CABG) - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • Table 2: World Historic Review for Coronary Artery Bypass Grafts (CABG) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • Table 3: World 15-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2021 & 2027
  • Table 4: World Coronary Artery Bypass Grafts (CABG) Market Analysis of Annual Sales in US$ for Years 2012 through 2027
  • Table 5: World Recent Past, Current & Future Analysis for Off-Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • Table 6: World Historic Review for Off-Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • Table 7: World 15-Year Perspective for Off-Pump by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
  • Table 8: World Recent Past, Current & Future Analysis for On-Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • Table 9: World Historic Review for On-Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • Table 10: World 15-Year Perspective for On-Pump by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
  • Table 11: World Recent Past, Current & Future Analysis for Minimally Invasive Direct by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • Table 12: World Historic Review for Minimally Invasive Direct by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • Table 13: World 15-Year Perspective for Minimally Invasive Direct by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
  • Table 14: World Recent Past, Current & Future Analysis for Saphenous Vein Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • Table 15: World Historic Review for Saphenous Vein Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • Table 16: World 15-Year Perspective for Saphenous Vein Grafts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
  • Table 17: World Recent Past, Current & Future Analysis for Internal Thoracic Artery Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • Table 18: World Historic Review for Internal Thoracic Artery Grafts by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • Table 19: World 15-Year Perspective for Internal Thoracic Artery Grafts by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
  • Table 20: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • Table 21: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • Table 22: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
III. MARKET ANALYSIS
UNITED STATES
  • Coronary Artery Bypass Grafts (CABG) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
  • Table 23: USA Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 24: USA Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • Table 25: USA 15-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2012, 2021 & 2027
  • Table 26: USA Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 27: USA Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • Table 28: USA 15-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2012, 2021 & 2027
CANADA
  • Table 29: Canada Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 30: Canada Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • Table 31: Canada 15-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2012, 2021 & 2027
  • Table 32: Canada Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 33: Canada Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • Table 34: Canada 15-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2012, 2021 & 2027
JAPAN
  • Coronary Artery Bypass Grafts (CABG) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
  • Table 35: Japan Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 36: Japan Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • Table 37: Japan 15-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2012, 2021 & 2027
  • Table 38: Japan Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 39: Japan Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • Table 40: Japan 15-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2012, 2021 & 2027
CHINA
  • Coronary Artery Bypass Grafts (CABG) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
  • Table 41: China Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 42: China Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • Table 43: China 15-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2012, 2021 & 2027
  • Table 44: China Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 45: China Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • Table 46: China 15-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2012, 2021 & 2027
EUROPE
  • Coronary Artery Bypass Grafts (CABG) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
  • Table 47: Europe Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • Table 48: Europe Historic Review for Coronary Artery Bypass Grafts (CABG) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • Table 49: Europe 15-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2021 & 2027
  • Table 50: Europe Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 51: Europe Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • Table 52: Europe 15-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2012, 2021 & 2027
  • Table 53: Europe Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 54: Europe Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • Table 55: Europe 15-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2012, 2021 & 2027
FRANCE
  • Coronary Artery Bypass Grafts (CABG) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
  • Table 56: France Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 57: France Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • Table 58: France 15-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2012, 2021 & 2027
  • Table 59: France Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 60: France Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • Table 61: France 15-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2012, 2021 & 2027
GERMANY
  • Coronary Artery Bypass Grafts (CABG) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
  • Table 62: Germany Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 63: Germany Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • Table 64: Germany 15-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2012, 2021 & 2027
  • Table 65: Germany Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 66: Germany Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • Table 67: Germany 15-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2012, 2021 & 2027
ITALY
  • Table 68: Italy Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 69: Italy Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • Table 70: Italy 15-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2012, 2021 & 2027
  • Table 71: Italy Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 72: Italy Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • Table 73: Italy 15-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2012, 2021 & 2027
UNITED KINGDOM
  • Coronary Artery Bypass Grafts (CABG) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
  • Table 74: UK Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 75: UK Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • Table 76: UK 15-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2012, 2021 & 2027
  • Table 77: UK Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 78: UK Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • Table 79: UK 15-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2012, 2021 & 2027
REST OF EUROPE
  • Table 80: Rest of Europe Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 81: Rest of Europe Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • Table 82: Rest of Europe 15-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2012, 2021 & 2027
  • Table 83: Rest of Europe Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 84: Rest of Europe Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • Table 85: Rest of Europe 15-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2012, 2021 & 2027
ASIA-PACIFIC
  • Coronary Artery Bypass Grafts (CABG) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
  • Table 86: Asia-Pacific Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 87: Asia-Pacific Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • Table 88: Asia-Pacific 15-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2012, 2021 & 2027
  • Table 89: Asia-Pacific Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 90: Asia-Pacific Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • Table 91: Asia-Pacific 15-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2012, 2021 & 2027
REST OF WORLD
  • Table 92: Rest of World Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 93: Rest of World Historic Review for Coronary Artery Bypass Grafts (CABG) by Segment - Off-Pump, On-Pump and Minimally Invasive Direct Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • Table 94: Rest of World 15-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Segment - Percentage Breakdown of Value Sales for Off-Pump, On-Pump and Minimally Invasive Direct for the Years 2012, 2021 & 2027
  • Table 95: Rest of World Recent Past, Current & Future Analysis for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • Table 96: Rest of World Historic Review for Coronary Artery Bypass Grafts (CABG) by Type - Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • Table 97: Rest of World 15-Year Perspective for Coronary Artery Bypass Grafts (CABG) by Type - Percentage Breakdown of Value Sales for Saphenous Vein Grafts, Internal Thoracic Artery Grafts and Other Types for the Years 2012, 2021 & 2027
IV. COMPETITION

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Genesee BioMedical, Inc.
  • Hancock Jaffe Laboratories, Inc.
  • HeartWare International, Inc.
  • Karl Storz GmbH & Co. KG
  • Maquet Holding B.V. & Co. KG
  • Medtronic PLC
  • Novadaq Technologies, Inc.
  • TandemLife